Skip to main content
AAO-HNSF 2023 Annual Meeting & OTO Experience Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Head and Neck Surgery

Quality of Life in Patients Treated for Pharyngolaryngeal Cancer

Tuesday, October 3, 2023
3:30 PM - 4:30 PM East Coast USA Time
Location: 207A

    Panelist(s)

  • YT

    Yao-Te Tsai, MD

    Dr.
    Chang Gung Memorial Hospital, Chiayi Branch
    Chiayi, Chiayi, Taiwan (Republic of China)

  • Yoon Woo Koh, MD, PhD

    Professor
    Department of Otorhinolaryngology, Yonsei University College of Medicine
    Seoul, Seoul-t'ukpyolsi, Republic of Korea

  • Andrea De Vito, PhD,MD

    ENT Unit Director
    Health Local Agency of Romagna
    FORLI', Emilia-Romagna, Italy

    • Moderator(s)

  • Sheng-Po Hao, MD, FACS, FICS

    Professor and Department Chairman
    Shin Kong Wu Ho-Su Memorial Hospital
    Taipei, Taipei, Taiwan (Republic of China)

Disclosure(s):
Yao-Te Tsai, MD: No relevant relationships to disclose.
Andrea De Vito, PhD,MD: No relevant relationships to disclose.
Sheng-Po Hao, MD, FACS, FICS: No relevant relationships to disclose.
PROGRAM DESCRIPTION: Although the hypopharyngeal cancer (HPC) accounts for only 3%–5% of all head and neck cancers, the prognosis of HPC remains unsatisfactory, which may be explained by the fact that approximately 60%–85% of patients with HPC patients were diagnosed as having stage III-IV disease at presentation. The lack of remarkable manifestations, the propensity of submucosal spread, and the high incidences of second primary cancer may also contribute the poor prognosis. Because of the substantial respiratory, deglutition, and speech functions in the pharyngolaryngeal area, the quality of life (QoL) is always a challenging issue in the management of oropharyngeal and pharyngolaryngeal cancer.

In this program, we have three sections. In the first section, Dr Tsai try to quantify the QoL and consider both QoL and survival by combining mean QoL scores at various intervals with survival function in patients with pharyngolaryngeal cancer. The derived quality-adjusted life-expectancy (QALE) and survival-weighted psychometric scores (SWPS) may serve as a reference for the allocation of cancer treatment resources and rehabilitation planning. Second, Dr De Vito would analyze the QoL in oropharyngeal and hypopharyngeal cancer, comparing QoL in those underwent conventional open surgical techniques and trans oral approach (robotic, Laser CO2). Finally, Dr Koh give us a comprehensive discussion on the QoL and functional outcome improves in patients who have undergone robotic surgery.

OUTCOME OBJECTIVE 1: Analyze the QALE and SWPS in patients with pharyngolaryngeal cancer.

OUTCOME OBJECTIVE 2: Compare the quality of life in patients underwent different surgical approaches.

OUTCOME OBJECTIVE 3: Understand the impact of transoral surgery on QoL in patients affected by head and neck cancer

BACKGROUND STATEMENT: We analyzed the updated literature data about conventional versus transoral surgery in patients affected by oropharyngeal and hypopharyngeal cancer, with the aim to confirm the improvement of QoL indexes in patients undergone transoral techniques.